Pharmaceutical Technology

JULY 14, 2022

Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients. These countries will have a smaller patient pool due to population size and will likely carry a price tag that is significantly below that of higher GDP countries.”.

Drugs 147

Drugs Medicine Marketing Development 147

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise.

Radiology 110

Radiology Marketing Genome Genomics 110

Rethinking Clinical Trials

SEPTEMBER 21, 2023

I would love for the financial incentive for fruits and vegetables for participants to remain a permanent strategy. I want to acknowledge that there’s definitely questions about the sustainability of types of behavior changes like the default options or even the economic incentives. My thoughts differ for each strategy.

Clinical Trials 130

Clinical Trials Clinical Trials Sales Trials 130

XTalks

NOVEMBER 10, 2020

Recalls and subsequent losses in sales can be financially detrimental to food companies. Implementing these technologies would require investing in handheld computers and tablets, barcode label printers and scanners, and special labels and tags. When it comes to foodborne illness, E. coli and Salmonella outbreaks occur year-round.

Production 105

Production Sales Manufacturing Regulation 105

XTalks

NOVEMBER 3, 2022

We have seen unprecedented demand for Mounjaro’s Type 2 diabetes launch in the US,” said Anat Ashkenazi, Lilly’s chief financial officer, on a call with analysts on Tuesday. The company is currently conducting a study to demonstrate Mounjaro’s weight loss effects and secured an FDA Fast Track tag in the obesity indication.

Sales 98

Sales FDA Approval Production Insulin 98

XTalks

DECEMBER 13, 2023

The company has been facing financial woes despite the big approvals. In 2022, bluebird won approvals for two gene therapies — Skysona for the treatment of the rare neurological disorder cerebral adrenoleukodystrophy (CALD) and Zynteglo for beta-thalassemia. Vertex-CRISPR’s Casgevy has a US list price of $2.2

Gene Therapy 98

Gene Therapy FDA Approval Gene In-Vivo 98

XTalks

JANUARY 28, 2022

Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. Immunocore’s commercial chief Ralph Torbay said the company has created a Kimmtrak Connect program to help patients access the therapy irrespective of their financial situation. The median treatment time is about 23 weeks (or 5.3

FDA Approval 98

FDA Approval Development Licensing Licensing 98

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

pharmaphorum

NOVEMBER 24, 2022

Despite J&J’s high hopes for the drug, sales have remained low, not warranting a mention in any of J&J’s quarterly financial updates since launch, and the company will look to the new data to try to encourage take-up.

Trials 52

Trials Sales Drugs Marketing 52

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. The broader movement across the industry is towards managing the financial cost of treatments. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

XTalks

FEBRUARY 14, 2023

Many farmers voluntarily invest in conservation programs that help provide economic and financial flexibility for their operation. Spending on the nutrition title alone is expected to push the price tag for the next Farm Bill to more than $1 trillion over the next ten years.

Packaging 98

Packaging Packaging Production Marketing 98

XTalks

SEPTEMBER 27, 2022

The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. To cover the monumental costs, both the drug developer and governments work together to offer financial support programs. Related: Bluebird’s $2.8M Gene Therapy Zynteglo Wins Landmark FDA Approval for Beta Thalassemia.

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

XTalks

DECEMBER 21, 2022

The company is a leader in the gene therapy space and had been facing significant financial challenges for the past several years. The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Drug Discovery World

JANUARY 30, 2024

Other Challenges: Limited insurance coverage: Many insurance companies are hesitant to cover CGTs due to their high price tags and limited long-term data. Developing financial assistance programs and exploring alternative funding models are important. Increased clinical data and evidence of cost-effectiveness can improve coverage.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. What makes cancer such a financial killer? OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87 The reasons aren’t mysterious.

Drugs 55

Drugs FDA Approval Medicine Containment 55

Pharmacy Checkers

JANUARY 30, 2020

Tagged the “pharma bro” for the cavalier attitude he fronted about his greed, Martin is actually currently behind bars. No, not for raising a drug price – otherwise the jails would overflow with pharma execs – but for financial fraud related to his work as hedge fund manager. That’s old news.

Drugs 54

Drugs Generic Drugs Cosmetics FDA Approval 54

Pharmaceutical Technology

OCTOBER 10, 2022

Concept: Israeli cloud cost management tools startup Finout has launched financial operations (FinOps) dashboards that abstract the cost of technical resources to business metrics and key performance indicators (KPIs). Each dashboard can be scheduled as a report creating a comprehensive FinOps reporting mechanism.

Production 130

Production Engineer Development Marketing 130

Pharmaceutical Technology

JANUARY 27, 2023

Jakub Hlávka, PhD, the executive director of the Healthcare Markets Initiative and Fellow at the University of Southern California Schaeffer Center, suggests the strategy behind this new warranty program could “minimise the [financial and clinical] risk for the provider and for the patient”. Do we know how to identify the right patients?”

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

pharmaphorum

DECEMBER 2, 2020

Leif Johansson, AZ’s chairman, did not mince his words, saying: “Pfizer’s approach throughout its pursuit of AstraZeneca appears to have been fundamentally driven by the corporate financial benefits to its shareholders of cost savings and tax minimisation. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag.

Sales 128

Sales Production Drugs Marketing 128

Cloudbyz

JUNE 1, 2023

These features enable organizations to provide a tailored experience for their users and maintain accurate financial records across diverse markets. They allow for a tailored and localized user experience, and accurate financial management across different markets. Users can also collaborate on files, add comments, and tag colleagues.

Compliance 87

Compliance Development Branding Production 87

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. As a result, Biopharma is at an inflection point with pressure from all angles. .

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

pharmaphorum

FEBRUARY 26, 2021

As with most of the pharma industry, J&J’s financials were hit by COVID uncertainty in 2020, the impacts of which may be felt for years to come. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. The post A history of Johnson & Johnson appeared first on.

Sales 125

Sales Production Pharma Companies Marketing 125

The Pharma Data

MAY 4, 2021

Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “I am extremely proud of the way we have begun 2021, delivering strong financial results in the first quarter. Business development activities completed in 2020 and 2021 impacted financial results in the periods presented (4). 2021 FINANCIAL GUIDANCE (3).

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40